Rigel Pharmaceuticals, Inc. (RIGL) Social Stream
Rigel Pharmaceuticals Inc (RIGL) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering RIGL.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 40 weeks, RIGL's average price target has gone down $1.1.
RIGL reports an average of 130.66% for its upside potential over the past 50 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
RIGL Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RIGL as an investment opportunity.
- In the context of all US stocks, Rigel Pharmaceuticals Inc's average analyst price target is higher than 33.33% of them.
- RIGL has a higher upside potential (average analyst target price relative to current price) than 427.39% of all US stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, Rigel Pharmaceuticals Inc's number of analysts covering the stock is higher than 142.57% of them.
- Rigel Pharmaceuticals Inc's variance in analysts' estimates is lower than -246% of stocks in the small market cap category.
Make investment decisions regarding RIGL using the data that counts. Try POWR Ratings for free.